cAMP-dependent protein kinase (PKA) and cGMP-dependent protein kinase (PKG) are the main effectors of distinct cyclic nucleotide pathways and are preferentially activated by cAMP or cGMP, respectively.
We recently characterized the isolated C-terminal cyclic nucleotide binding domain (CNB-B) of the human PKG Iβ as highly cGMP-selective (manuscript in preparation). In a crystal structure of the CNB-B two novel cGMP-specific interaction sites were identified in addition to the previously described threonine residue (T317) in the phosphate binding cassette [1]. Mutation of each individual site resulted in reduced cGMP-selectivity and interfered with cGMP-dependent activation of PKG Iβ.
To gain further insight into the molecular basis of cyclic nucleotide selectivity, we inserted two cGMP-specific interaction sites into the CNB-B of human PKA RIα by mutating corresponding residues. We hypothesize that this way cGMP-specific interaction contacts can be created in PKA and thereby modulate cAMP-selectivity [1,2].
%0 Generic
%1 lorenz2013transforming
%A Lorenz, R.
%A Moon, E.
%A Huang, G.
%A Reger, A.
%A Kim, J.
%A Franz, E.
%A Bertinetti, D.
%A Kim, C.
%A Herberg, F.
%D 2013
%J BMC Pharmacology and Toxicology
%K herberg ip myown
%N Suppl 1
%P P41
%R 10.1186/2050-6511-14-S1-P41
%T Transforming PKA into PKG - a structure-function approach to understand cyclic nucleotide selectivity
%U http://www.biomedcentral.com/2050-6511/14/S1/P41
%V 14
@presentation{lorenz2013transforming,
added-at = {2013-09-16T15:26:58.000+0200},
author = {Lorenz, R. and Moon, E. and Huang, G. and Reger, A. and Kim, J. and Franz, E. and Bertinetti, D. and Kim, C. and Herberg, F.},
biburl = {https://www.bibsonomy.org/bibtex/21bcfc354859bf0034be1f064ebc3a5d0/biochemie},
description = {cAMP-dependent protein kinase (PKA) and cGMP-dependent protein kinase (PKG) are the main effectors of distinct cyclic nucleotide pathways and are preferentially activated by cAMP or cGMP, respectively.
We recently characterized the isolated C-terminal cyclic nucleotide binding domain (CNB-B) of the human PKG Iβ as highly cGMP-selective (manuscript in preparation). In a crystal structure of the CNB-B two novel cGMP-specific interaction sites were identified in addition to the previously described threonine residue (T317) in the phosphate binding cassette [1]. Mutation of each individual site resulted in reduced cGMP-selectivity and interfered with cGMP-dependent activation of PKG Iβ.
To gain further insight into the molecular basis of cyclic nucleotide selectivity, we inserted two cGMP-specific interaction sites into the CNB-B of human PKA RIα by mutating corresponding residues. We hypothesize that this way cGMP-specific interaction contacts can be created in PKA and thereby modulate cAMP-selectivity [1,2].
},
doi = {10.1186/2050-6511-14-S1-P41},
interhash = {21c56d41e63c96f6329fc79ac4e1013b},
intrahash = {1bcfc354859bf0034be1f064ebc3a5d0},
issn = {2050-6511},
journal = {BMC Pharmacology and Toxicology},
keywords = {herberg ip myown},
number = {Suppl 1},
pages = {P41},
timestamp = {2016-11-04T11:47:23.000+0100},
title = {Transforming PKA into PKG - a structure-function approach to understand cyclic nucleotide selectivity},
url = {http://www.biomedcentral.com/2050-6511/14/S1/P41},
volume = 14,
year = 2013
}